Belite Bio (BLTE) Operating Expenses (2022 - 2026)

Belite Bio's Operating Expenses history runs 5 years deep, the most recent figure standing at $32.7 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 110.63% year-over-year to $32.7 million; the TTM figure through Mar 2026 stood at $68.7 billion (up 116.91% YoY), while the FY2025 annual figure was $84.2 million, up 110.54% from the prior year.
• Operating Expenses was $32.7 million for Q1 2026 at Belite Bio, down from $28.1 billion in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $28.1 billion in Q4 2025 to a low of $6.7 million in Q4 2022.
• Historically, Operating Expenses has averaged $8.0 billion across 5 years, with a median of $6.9 billion in 2023.
• The sharpest annual moves came in 2024 and 2025: Operating Expenses soared 164630.41% in 2024, then sank 99.81% in 2025.
• A 5-year view of Operating Expenses shows it stood at $6.7 million in 2022, then increased by 3.48% to $7.0 million in 2023, then jumped by 164630.41% to $11.5 billion in 2024, then jumped by 145.06% to $28.1 billion in 2025, then sank by 99.88% to $32.7 million in 2026.
• The last three Operating Expenses figures came in at $32.7 million (Q1 2026), $28.1 billion (Q4 2025), and $23.0 billion (Q3 2025), per Business Quant data.